Quarterly report pursuant to Section 13 or 15(d)

Stock Plans

v3.8.0.1
Stock Plans
3 Months Ended
Mar. 31, 2018
Stock Plans [Abstract]  
Stock Plans [Text Block]
2.
Stock Plans
 
The following table summarizes the stock-based compensation expense recorded for awards under the stock option plans for the three month periods ended March 31, 2018 and 2017:
 
 
 
Three Months Ended 
March 31,
 
(in thousands, except per share amounts)
 
2018
 
2017
 
Research and development
 
$
163
 
$
117
 
General and administrative
 
 
269
 
 
304
 
 
 
 
 
 
 
 
 
Total stock-based compensation expenses
 
$
432
 
$
421
 
 
No tax benefit was recognized related to stock-based compensation expense since we have incurred operating losses and we have established a full valuation allowance to offset all the potential tax benefits associated with our deferred tax assets.
 
We use the Black-Scholes-Merton option-pricing model with the following assumptions to estimate the stock-based compensation expense for the three month period ended March 31, 2018 and 2017:
 
 
 
Three Months Ended 
March 31,
 
 
 
2018
 
2017
 
Weighted-average risk-free interest rate
 
 
2.75
%
 
2.16
%
Expected dividend payments
 
 
 
 
 
Expected holding period (years)1
 
 
6.4
 
 
6.6
 
Weighted-average volatility factor2
 
 
0.89
 
 
0.88
 
Estimated forfeiture rates for options granted3
 
 
26
%
 
28
%
   
(1)
Expected holding period is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and the expectations of future employee behavior.
 
(2)
Weighted average volatility is based on the historical volatility of our common stock.
 
(3)
Estimated forfeiture rates are based on historical data.
 
Options to purchase approximately 945,000 and approximately 436,000 common shares were granted during the three month periods ended March 31, 2018 and 2017, respectively.
  
The following table summarizes option activity for the three month period ended March 31, 2018:
 
(in thousands, except per share amounts)
 
Options
 
Weighted 
Average 
Exercise 
Price
 
Weighted
Average 
Remaining 
Option 
Term
 
Aggregate 
Intrinsic 
Value
 
Outstanding at January 1, 2018
 
 
2,728
 
$
4.32
 
 
5.75
 
$
30
 
Granted
 
 
945
 
 
0.97
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
 
 
Expired or cancelled
 
 
 
 
 
 
 
 
 
 
 
Forfeited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2018
 
 
3,673
 
$
3.46
 
 
6.64
 
$
76
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at March 31, 2018
 
 
2,416
 
$
4.48
 
 
5.67
 
$
19
 
  
No shares of restricted stock were awarded to employees, directors and consultants during the three month periods ended March 31, 2018 and 2017.
 
As of March 31, 2018, there was approximately $892,000 of total unrecognized compensation expense related to non-vested stock options. This expense is expected to be recognized over a weighted-average period of approximately 0.9 years.